Strategies in Trauma and Limb Reconstruction

Register      Login

VOLUME 15 , ISSUE 2 ( May-August, 2020 ) > List of Articles

Original Article

An Initial Study into the Role of Teriparatide in Absent or Delayed Regenerate Formation during Distraction Osteogenesis: A Case Series

Bharath Patil, Rajeev Kansay, Sandeep Gupta, Anil Kapoor, Anmol Sharma, Naveen Mittal

Keywords : Delayed callus, Distraction osteogenesis, Poor regenerate, Teriparatide,Absent callus

Citation Information : Patil B, Kansay R, Gupta S, Kapoor A, Sharma A, Mittal N. An Initial Study into the Role of Teriparatide in Absent or Delayed Regenerate Formation during Distraction Osteogenesis: A Case Series. 2020; 15 (2):117-120.

DOI: 10.5005/jp-journals-10080-1464

License: CC BY-NC-SA 4.0

Published Online: 01-01-2021

Copyright Statement:  Copyright © 2020; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Purpose: Distraction osteogenesis has been used for post-traumatic segmental bone defects. Absent or delayed callus formation in the distraction gap can lead to significant morbidity and affect the clinical outcome. Experimental evidence in animal models has demonstrated that teriparatide enhances the consolidation of regenerate and also strengthens it. This study aimed to report our experience with recombinant teriparatide therapy for patients with regenerate insufficiency. Materials and methods: Nine out of 43 patients undergoing limb lengthening using the limb reconstruction system (LRS) fixator were diagnosed with regenerate insufficiency. With informed consent, these patients received a therapeutic regime of 20 μg of teriparatide administered subcutaneously once daily for a period of 3 months. Results: The mean age in the sample was 40.22 years (SD 17.87). Regenerate insufficiency was diagnosed at a mean of 4.94 months (range 2.5–9 months) from surgery. Teriparatide injections were started at a mean of 6.94 months (range 4.5–11 months) from surgery. The sites of regenerate insufficiency were tibia (n = 5) and femur (n = 4). Favourable radiographic progress in visibility of callus was seen at a mean duration of 9.4 weeks (range 8–12 weeks) from the initiation of teriparatide therapy. No systemic complications were encountered. Conclusion: The initiation of teriparatide treatment as described in this study may be successful in triggering the osteogenic potential within poor regenerate and help in consolidation and avoid more invasive surgical procedures.


PDF Share
  1. Ilizarov G. Clinical application of the tension-stress effect for limb lengthening. Clin Orthopaed Relat Res 1990;250(250):8–26. DOI: 10.1097/00003086-199001000-00003.
  2. Velazquez RJ, Bell DF, Armstrong PF, et al. Complications of use of the Ilizarov technique in the correction of limb deformities in children. J Bone Joint Surg Am 1993;75(8):1148–1156. DOI: 10.2106/00004623-199308000-00004.
  3. Garcia-Cimbrelo E, Olsen B, Ruiz-Yague M, et al. Ilizarov technique: results and difficulties. Clin Orthop Relat Res 1992(283):116–123.
  4. Eldridge JC, Bell DF. Problems with substantial limb lengthening. Orthop Clin North Am 1991;22(4):625–631.
  5. Claes L, Augat P, Schorlemmer S, et al. Temporary distraction and compression of a diaphyseal osteotomy accelerates bone healing. J Orthop Res 2008;26(6):772–777. DOI: 10.1002/jor.20588.
  6. Mora R. Nonunion of the long bones: diagnosis and treatment with compression-distraction techniques. Milan, Italy: Springer; 2006.
  7. Hamdy RC, Rendon JS, Tabrizian M. Distraction osteogenesis and its challenges in bone regeneration. Bone Regeneration Tal H, ed. ch. 8 pp. 177–204. InTech, Rijeka, Croatia 2012.
  8. Makhdom AM, Hamd RC. The role of growth factors on acceleration of bone regeneration during distraction osteogenesis. Tissue Eng Part B Rev 2013;19(5):442–453. DOI: 10.1089/ten.teb.2012.0717.
  9. Aronson J. Experimental and clinical experience with distraction osteogenesis,. Cleft Palate Craniofac J 1994;31(6):473–482. DOI: 10.1597/1545-1569_1994_031_0473_eacewd_2.3.co_2.
  10. Sabharwal S. Enhancement of bone formation during distraction osteogenesis: pediatric applications. J Am Acad Orthopaed Surg 2011;19(2):101–111. DOI: 10.5435/00124635-201102000-00005.
  11. Gebauer D, Correll J. Pulsed low-intensity ultrasound: anew salvage procedure for delayed unions and non unions after leg lengthening in children. J Pediat Orthopaed 2005;25(6):750–754. DOI: 10.1097/01.bpo.0000173245.12184.7e.
  12. Eyres KS, Saleh M, Kanis JA. Effect of pulsed electromagnetic fields on bone formation and bone loss during limb lengthening. Bone 1996;18(6):505–509. DOI: 10.1016/8756-3282(96)00070-1.
  13. Ye B, Li Y, Zhu S, et al. Effects of intermittent low-dose parathyroid hormone treatment on rapid mandibular distraction osteogenesis in rabbits. J Oral Maxillofac Surg 2017;75(8):1722–1731. DOI: 10.1016/j.joms.2017.04.010.
  14. Seebach C, Skripitz R, Andreassen TT, et al. Intermittent parathyroid hormone (1-34) enhances mechanical strength and density of new bone after distraction osteogenesis in rats. J Orthop Res 2004;22(3):472–478. DOI: 10.1016/j.orthres.2003.08.018.
  15. Catagni M. Imaging techniques: the radiographic classification of bone regenerate during distraction. Operative Principles of Ilizarov Maiocchi AB, Aronson J, ed., London: Williams & Wilkins; 1991. pp. 53–57.
  16. Gupta S, Malhotra A, Mittal N, et al. The management of infected nonunion of tibia with a segmental defect using simultaneous fixation with a monorail fixator and a locked plate. Bone Joint J 2018;100-B(8):1094–1099. DOI: 10.1302/0301-620X.100B8.BJJ-2017-1442.R1.
  17. Kiely P, Ward K, Bellemore CM, et al. Bisphosphonate rescue in distraction osteogenesis: a case series. J Pediatr Orthop 2007;27(4):467–471. DOI: 10.1097/01.bpb.0000271326.41363.d1.
  18. Aleksyniene R, Thomsen JS, Eckardt H, et al. Parathyroid hormone PTH(1-34) increases the volume, mineral content, and mechanical properties of regenerated mineralizing tissue after distraction osteogenesis in rabbits. Acta Orthop 2009;80(6):716–723. DOI: 10.3109/17453670903350032.
  19. Sheyn D, Cohn Yakubovich D, Kallai I, et al. PTH promotes allograft integration in a calvarial bone defect. Mol Pharm 2013;10(12):4462. DOI: 10.1021/mp400292p.
  20. Wagner F, Vach W, Augat P, et al. Daily subcutaneous teriparatide injection increased bone mineral density of newly formed bone after tibia distraction osteogenesis, a randomized study. Injury 2019;50(8):1478–1482. DOI: 10.1016/j.injury.2019.06.001.
  21. Subbiah V, Madsen VS, Raymond AK, et al. Of mice and men: divergent risks of teriparatide-induced osteosarcoma. Osteoporos Int 2010;21(6):1041–1045. DOI: 10.1007/s00198-009-1004-0.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.